» Articles » PMID: 12657923

Toxicokinetics of Nortriptyline and Amitriptyline: Two Case Reports

Overview
Journal Ther Drug Monit
Specialty Pharmacology
Date 2003 Mar 27
PMID 12657923
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Two cases are presented of intentional intoxications with the tricyclic antidepressants (TCAs) nortriptyline (NT) and amitriptyline (AT). The peak plasma concentrations were 2290 microg/L and 2900 microg/L, respectively. The active metabolites E-10-hydroxynortriptyline (EHNT) and Z-10-hydroxynortriptyline (ZHNT) profiles were quite different as monitored for 5 to 10 days after presumed drug intake. In conclusion, these cases illustrate that (1) metabolite formation and elimination after intake of an overdose dose of NT and AT are stereoselective, and (2) NT and EHNT toxicokinetics and toxicodynamics are quite different. It also shows that a patient with a severe TCA overdose can still survive if he or she receives appropriate and quick supportive care, even if the prognostic markers QRS time, coma grade, and serum TCA levels predict poor outcome.

Citing Articles

Plasma concentration of amitriptyline and metabolites after resuscitation from cardiopulmonary arrest following an overdose: A case report.

Ando M, Tamura R, Nakasako S, Takimoto S, Ariyoshi K, Yamaguchi M Clin Case Rep. 2021; 9(2):805-811.

PMID: 33598249 PMC: 7869369. DOI: 10.1002/ccr3.3656.


Amitriptyline-induced ventricular tachycardia: a case report.

Sabah K, Chowdhury A, Islam M, Saha B, Kabir S, Kawser S BMC Res Notes. 2017; 10(1):286.

PMID: 28709467 PMC: 5513042. DOI: 10.1186/s13104-017-2615-8.


Prolonged toxicity after amitriptyline overdose in a patient deficient in CYP2D6 activity.

Smith J, Curry S J Med Toxicol. 2011; 7(3):220-3.

PMID: 21614669 PMC: 3550197. DOI: 10.1007/s13181-011-0158-2.


Pharmacokinetic considerations in clinical toxicology: clinical applications.

Roberts D, Buckley N Clin Pharmacokinet. 2007; 46(11):897-939.

PMID: 17922558 DOI: 10.2165/00003088-200746110-00001.


A case report of a poor metabolizer of CYP2D6 presented with unusual responses to nortriptyline medication.

Lee S, Ki C, Hong K, Kim J J Korean Med Sci. 2004; 19(5):750-2.

PMID: 15483356 PMC: 2816343. DOI: 10.3346/jkms.2004.19.5.750.